€53.00+€0.05 (+0.09%)
Recordati Industria Chimica e Farmaceutica S.p.A.’s quoted price sits in the upper half of its reported 52-week range, 2.66% below the high.
Loading market information…
MIL · ELN.MI · EUR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 04:35 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
EL.En. S.p.A.’s quoted price sits in the upper half of its reported 52-week range, 7.03% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
EL.En. S.p.A.’s forward annual dividend is €0.25 per share, paid annual. The forward yield is 1.52% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
EL.En. S.p.A.’s next earnings report is currently expected on Nov 13, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow EL.En. S.p.A.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
EL.En. S.p.A. is a global leader in the development, manufacturing, marketing, and distribution of advanced laser systems. The company supplies a wide array of medical laser equipment for applications in physiotherapy, orthopedics, traumatology, rheumatology, dermatology, sports and rehabilitative medicine, surgery, aesthetics, and art. Additionally, EL.En. offers industrial laser sources and integrated systems engineered for precise cutting, welding, marking, and engraving across numerous materials. Its product portfolio includes various laser source technologies, such as liquid, solid-state, semiconductor, and gas lasers. Complementing its product offerings, the company provides comprehensive after-sales services, including spare parts supply, expert consultation, and technical support. Established in 1981, EL.En. S.p.A. is headquartered in Calenzano, Italy.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:41 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q3 2024 |
|---|
| Nov 14, 2024 |
| €0.19 |
| €153.26M-23.56% vs estimate |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€53.00+€0.05 (+0.09%)
Recordati Industria Chimica e Farmaceutica S.p.A.’s quoted price sits in the upper half of its reported 52-week range, 2.66% below the high.
$20.24+$0.81 (+4.17%)
Stevanato Group S.p.A.’s quoted price sits in the upper half of its reported 52-week range, 25.04% below the high.
€80.60-€1.16 (-1.42%)
DiaSorin S.p.A.’s quoted price sits in the upper half of its reported 52-week range, 2.07% below the high.
€13.07+€0.11 (+0.85%)
Amplifon S.p.A.’s quoted price sits in the upper half of its reported 52-week range, 13.36% below the high.
€1.94+€0.02 (+0.99%)
Safilo Group S.p.A.’s quoted price sits in the upper half of its reported 52-week range, 15.04% below the high.
€72.00+€0.70 (+0.98%)
Pharmanutra S.p.A.’s quoted price sits in the upper half of its reported 52-week range, 24.92% below the high.
€20.95-€0.05 (-0.24%)
Philogen S.p.A.’s quoted price sits in the lower half of its reported 52-week range, 19.42% below the high.
€15.12-€0.02 (-0.13%)
GPI S.p.A.’s quoted price sits in the lower half of its reported 52-week range, 19.06% below the high.
